TSHR and cancer: Pooled cancer prevalence in reported studies concerning both BRAF mutation and TSHR mRNA were rather high (45% and 44% respectively), comparable to the highest value observed and reported in South Korea (47.4%) [9], suggesting possible selection bias (Table 1).